Intimation of Grant of Options under Glenmark Pharmaceuticals Limited Employee Stock Option Scheme, 2016
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
On May 22, 2025, the Nomination and Remuneration Committee of Glenmark Pharmaceuticals granted 1,19,318 stock options to eligible employees under the company's Employee Stock Option Scheme, 2016. Each option gives the right to one equity share of Re. 1 face value, at an exercise price of Rs. 600 per share. The scheme is compliant with SEBI (SBEB) Regulations, 2021. Vesting will start after a minimum of one year from the grant date and may extend up to six years, subject to lock-in conditions decided by the Board or NRC.
This is a routine ESOP allotment with a small dilution (~1.19 lakh shares) relative to Glenmark's overall share base, so it should have minimal impact on existing shareholders. The Rs. 600 exercise price is close to recent market levels, indicating the grant is meant to incentivise and retain employees rather than offer a deeply discounted benefit.